Regulatory Correspondence. COPLEY and HMRI shall make availa▇▇▇ ▇▇ each other, within three (3) days of receipt, regulatory correspondence covering the following issues: regulatory letters, Product recalls, withdrawal of Product, and correspondence bearing on the safety and efficacy of the Product.
Appears in 2 contracts
Sources: Micronized Glyburide Agreement (Copley Pharmaceutical Inc), Pentoxifylline Agreement (Copley Pharmaceutical Inc)
Regulatory Correspondence. COPLEY and HMRI shall make availaavai▇▇▇▇▇ ▇▇ to each other, within three (3) days of receipt, regulatory correspondence covering the following issues: regulatory letters, Product recalls, withdrawal of Product, and correspondence bearing on the safety and efficacy of the Product. [*] Confidential portion has been omitted pursuant to a request for confidential treatment and has been filed separately with the Commission.
Appears in 1 contract